PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX)

Historical Holders from Q2 2020 to Q3 2025

Symbol
PLRX on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
61,709,822
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
50,406,732
Holdings value
$74,592,710
% of all portfolios
0%
Number of holders
97
Number of buys
33
Number of sells
68
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TANG CAPITAL MANAGEMENT LLC 9.6% $9,198,699 5,859,044 TANG CAPITAL MANAGEMENT, LLC 03 Mar 2025
Woodline Partners LP 7.3% $6,667,129 4,504,817 Woodline Partners LP 30 Sep 2025
Point72 Asset Management, L.P. 6.7% $6,536,027 4,085,017 Point72 Asset Management, L.P. 27 Aug 2025
MORGAN STANLEY 6.1% $5,269,642 3,737,335 Morgan Stanley 30 Jun 2025
VANGUARD GROUP INC 4.9% $3,482,724 3,002,348 The Vanguard Group 30 Jun 2025
Redmile Group, LLC 4.8% $4,545,900 2,895,478 Redmile Group, LLC 31 Dec 2024
BlackRock, Inc. 3.4% $2,440,674 2,104,574 BlackRock, Inc. 30 Jun 2025
FMR LLC 0.2% $207,230 131,993 FMR LLC 28 Feb 2025
PRICE T ROWE ASSOCIATES INC /MD/ 0.1% $137,648 87,674 T. Rowe Price Associates, Inc. 31 Mar 2025
As of 30 Sep 2025 PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) has 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 50,406,732 shares of 61,709,822 outstanding shares and own 82% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) own 73% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Holdings Value Nb Shares Share Change %
TANG CAPITAL MANAGEMENT LLC 9.7% $8,885,100 6,003,446 +0.06%
Woodline Partners LP 7.3% $6,667,129 4,504,817 +92%
Point72 Asset Management, L.P. 7% $6,420,823 4,338,394
MORGAN STANLEY 5.7% $5,190,785 3,507,288 -6.6%
Blue Owl Capital Holdings LP 4.8% $4,394,415 2,969,199 0%
VANGUARD GROUP INC 4.5% $4,108,388 2,775,938 -7.5%
ACADIAN ASSET MANAGEMENT LLC 3.8% $3,501,000 2,369,542 +45%
CITADEL ADVISORS LLC 3.8% $3,462,413 2,339,468 -0.7%
JPMORGAN CHASE & CO 3.5% $3,153,123 2,130,489 +8.8%
Redmile Group, LLC 2.6% $2,355,709 1,591,695 -2.5%
BlackRock, Inc. 2.3% $2,102,878 1,420,863 -33%
UBS Group AG 2.1% $1,956,585 1,322,017 -50%
Peapod Lane Capital LLC 1.8% $1,623,616 1,097,028 +23%
TWO SIGMA ADVISERS, LP 1.7% $1,587,300 1,072,500 +136%
RENAISSANCE TECHNOLOGIES LLC 1.6% $1,497,467 1,011,802 +406%
GREAT POINT PARTNERS LLC 1.4% $1,258,000 850,000 0%
Eversept Partners, LP 1.3% $1,220,399 824,594
Monaco Asset Management SAM 1.3% $1,217,586 822,693 +17%
TWO SIGMA INVESTMENTS, LP 1.3% $1,159,217 783,255 +182%
BANK OF AMERICA CORP /DE/ 1.1% $1,047,923 708,056 +47%
GEODE CAPITAL MANAGEMENT, LLC 0.95% $869,823 587,409 +0.83%
GOLDMAN SACHS GROUP INC 0.9% $821,512 555,076 -7%
MILLENNIUM MANAGEMENT LLC 0.87% $795,259 537,337 -37%
BESSEMER GROUP INC 0.86% $787,000 532,079 -0.01%
XTX Topco Ltd 0.76% $691,136 466,984 +8.9%

Institutional Holders of PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 50,406,732 $74,592,710 +$1,536,230 $1.48 97
2025 Q2 51,491,424 $59,725,484 -$8,565,167 $1.16 112
2025 Q1 57,869,854 $78,126,006 -$216,549,992 $1.35 138
2024 Q4 64,754,179 $852,599,671 +$21,507,892 $13.17 158
2024 Q3 63,483,171 $714,277,363 -$5,607,911 $11.21 149
2024 Q2 63,896,951 $686,885,070 -$18,557,994 $10.75 141
2024 Q1 65,187,064 $971,256,923 +$41,504,855 $14.90 133
2023 Q4 62,712,668 $1,135,768,923 +$100,850,737 $18.11 133
2023 Q3 60,161,028 $1,043,150,835 +$29,447,949 $17.34 134
2023 Q2 58,042,121 $1,051,734,729 +$9,423,269 $18.12 141
2023 Q1 56,237,135 $1,495,380,265 +$312,862,520 $26.60 143
2022 Q4 44,702,851 $864,087,630 -$14,811,927 $19.33 123
2022 Q3 45,386,319 $948,113,021 +$327,405,105 $20.89 107
2022 Q2 30,133,558 $241,439,678 -$11,245,591 $8.01 81
2022 Q1 31,426,255 $220,339,413 +$4,111,275 $7.01 85
2021 Q4 30,850,148 $416,473,043 +$5,468,177 $13.50 81
2021 Q3 30,380,086 $512,798,759 -$14,863,235 $16.88 75
2021 Q2 30,676,131 $893,270,740 -$1,364,693 $29.12 80
2021 Q1 30,719,770 $1,208,139,215 +$88,069,181 $39.33 76
2020 Q4 28,511,470 $647,801,804 +$7,265,154 $22.72 57
2020 Q3 28,195,401 $635,735,229 +$17,040,139 $22.65 53
2020 Q2 26,908,341 $868,442,000 +$868,442,000 $32.46 36